Prior authorization forces doctors to spend 13 hours a week fighting insurers. New federal rules are changing that. Here's what you need to know.

Proving AI ROI in prior authorization, St. Luke's, MetroHealth and Vanderbilt improved medication access and reduced clinician burden with AI.

Prior authorizations create substantial administrative and financial burdens on physicians and patients and can disrupt the continuity of care. This commentary discusses the current prior ...

While artificial intelligence solutions can reduce administrative burden in prior authorizations and billing, organizations are reporting increased transaction volumes and higher costs, according to a ...

Health insurers covering more than 250 million Americans recently unveiled a sweeping plan to streamline and reduce prior authorization requirements — a pledge met with cautious optimism by revenue ...

Prior authorization has long been a sticking point between payers and providers, with payers arguing that it’s necessary to control costs and ensure that care is medically necessary and providers ...

KANSAS CITY, MO, UNITED STATES, January 27, 2026 /EINPresswire.com/ — Onyx, the leading healthcare interoperability platform provider and 2025 Best in KLAS ® for ...

Prior authorization has become one of the clearest points where administrative complexity directly affects patient care. For ...

Three new studies highlighted the growing burden of prior authorization on both oncologists and patients. Findings from a survey of radiation oncologists, for instance, revealed that more than 80% ...

In 2025 alone, doctors and legislators across the country have already introduced more than 100 pieces of legislation meant to reform prior authorization. The cumbersome approval process is a leading ...

Prior authorization is a major thorn in the side of providers, adding to their administrative burden and hampering their ability to provide timely care to patients. It is also a source of frustration ...

The Centers for Medicare & Medicaid Services (CMS) has proposed extending its interoperability and prior authorization requirements to include drugs, aiming for faster, more transparent approvals. The ...